Comparison of safety and efficacy of convalescent plasma with fresh frozen plasma in severe covid-19 patients

Abstract background: Role of Convalescent plasma (COPLA) to treat severe COVID-19 is under investigation. We compared efficacy and safety of COPLA with fresh frozen plasma (FFP) in severe COVID-19 patients. Methods: One group received COPLA with standard medical care (n = 14), and another group received random donor FFP, as control with standard medical care (n = 15) in severe COVID-19 disease. Results: The proportion of patients free of ventilation at day seven were 78.5% in COPLA group, and 93.3 % in control group were not significant (p= 0.258). However, improved respiratory rate, O2 saturation, SOFA score, and Ct value were observed in the COPLA group. No serious adverse events were noticed by plasma transfusion in both groups.

Bibliographic Details

Main Authors:	BAJPAI,MEENU, MAHESHWARI,ASHISH, KUMAR,SURESH, CHHABRA,KARAN, KALE,PRATIBHA, NARAYANAN,ASHAD, GUPTA,AMITA, GUPTA,EKTA, TREHANPATI,NIRUPAMA, AGARWAL,RESHU, GUPTA,KAMINI, BHARDWAJ,ANKIT, ISLAM,MOJAHIDUL, SINGH,RAVINDER, YADAV,PUSHPA, KUMAR,GURESH, SARIN,SHIV K.
Format:	Digital revista
Language:	English
Published:	Academia Brasileira de Ciências 2022
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652022000600701
Tags:	Add Tag No Tags, Be the first to tag this record!